Featured Research

from universities, journals, and other organizations

inflammatory bowel disease emerges as a global disease

Date:
January 5, 2012
Source:
American Gastroenterological Association
Summary:
The incidence and prevalence of inflammatory bowel disease are increasing with time and in different regions around the world.

The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

"Insight into the worldwide epidemiology of inflammatory bowel disease is important for the identification of geographic patterns and time trends," said Gilaad G. Kaplan, MD, MPH, of the University of Calgary and lead author of this study. "Our findings will help researchers estimate the global public health burden of inflammatory bowel disease so that appropriate health-care resources are allocated, and targeted research is conducted in specific geographic regions," added Dr. Kaplan, an Alberta Innovates -- Health Solutions population health investigator.

Population-based epidemiologic data of IBD collected in a standardized fashion in developing nations are sparse. To properly interpret the incidence or prevalence data and evaluate time trends, researchers conducted a systematic review of all population-based studies that describe the incidence and/or prevalence of IBD. They found that the incidence of IBD is increasing or stable in virtually every region of the world that has been studied.

Researchers found that the highest prevalence of IBD worldwide was reported in Canada and Europe, whereas Asia had a lower prevalence of IBD. In developing nations, IBD was a rare occurrence; however, as these nations have become more industrialized, the incidence of IBD has increased. Gender differences were inconsistent, suggesting that the disease occurred equally among females and males.

Universally, incidence rates for both Crohn's disease and ulcerative colitis were highest among individuals who were between 20 and 40 years old. Thus, IBD affects individuals in the most healthy and productive years of life, resulting in long-term cost to the patient, health-care system and society.

Despite more than 200 publications in the literature on IBD, this study highlights the need for incidence and prevalence data in many regions of the world, particularly from developing countries. Future studies in these regions are required to provide important insights into the etiology of IBD.

The two major illnesses that are recognized most often as inflammatory bowel disease are ulcerative colitis and Crohn's disease. The most common symptoms of ulcerative colitis, which occurs in the inner lining of the colon (large intestine) or rectum, are diarrhea, abdominal cramps and rectal bleeding. Patients suffering from Crohn's disease, an inflammation and ulceration process that occurs in the deep layers of the intestinal wall, experience pain in the abdomen -- often in the lower right side -- diarrhea, weight loss and occasionally bleeding.


Story Source:

The above story is based on materials provided by American Gastroenterological Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Natalie A. Molodecky, Ing Shian Soon, Doreen M. Rabi, William A. Ghali, Mollie Ferris, Greg Chernoff, Eric I. Benchimol, Remo Panaccione, Subrata Ghosh, Herman W. Barkema, Gilaad G. Kaplan. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology, 2012; 142 (1): 46 DOI: 10.1053/j.gastro.2011.10.001

Cite This Page:

American Gastroenterological Association. "inflammatory bowel disease emerges as a global disease." ScienceDaily. ScienceDaily, 5 January 2012. <www.sciencedaily.com/releases/2012/01/120104135402.htm>.
American Gastroenterological Association. (2012, January 5). inflammatory bowel disease emerges as a global disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/01/120104135402.htm
American Gastroenterological Association. "inflammatory bowel disease emerges as a global disease." ScienceDaily. www.sciencedaily.com/releases/2012/01/120104135402.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins